Anti-PCSK9 antibodies, formulations, dosing, and methods of use
US9266961B2 · kind B2 · utility
3Cited by
68References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2013 |
| Grant date | Feb 23, 2016 |
| Priority date | — |
| Expiry date | Jun 14, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.